By Kodchaporn Supramonklachai, Tax Advisor
In accordance with Royal Decree No. 733, dated 8 November 2021, Antigen Test Kits purchased by employers for the purpose of testing their employees for COVID-19 shall be exempt from corporate income tax (“CIT”) for companies or juristic partnerships for an additional 50% of their cost. This relates to the cost of the purchase of test kits and reagents related to the diagnosis of SARS-CoV-2 (COVID-19) for antigen self-test kits (“ATKs”) for use by their employees from 14 September 2021 to 31 March 2022, This effectively means that the Revenue Department (“RD”) allows companies or juristic partnerships to claim an additional expense of 50% (i.e. Deduction of 1.5 times of the cost) for the purchase of ATKs. The ATK test must meet the safety standards specified by the Ministry of Public Health and the purpose is to support and relieve the burden for business and to encourage companies to use these tests as companies’ operations returning to normal, will assist the country’s economic recovery from the pandemic.
Kodchaporn Supramonklachai is a Thailand Tax Advisor with RSM Thailand Limited who supply tax service Bangkok and should you wish to discuss this article in more detail or require information about any of our consulting services including accounting, payroll & tax, please contact her on [email protected]